2651 - 2675 of 6568 Results
Title
Year
-
OPENTitle: DAT-SPECT-based subtype and stage inference in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01347-2Best OA location URL: https://www.nature.com/articles/s41531-026-01347-2_reference.pdfCitation Count: 1
-
OPENTitle: Orientation selective deep brain stimulationJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 14Issue #: 1Start Page: 016016End Page: 016016Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/1741-2552/aa5238Best OA location URL: http://doi.org/10.1088/1741-2552/aa5238Citation Count: 51
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950Citation Count: 0
-
OPENTitle: Parkinson's disease prevalence in Fabry disease: A survey studyJournal Name: Molecular Genetics and Metabolism ReportsPublisher: Elsevier BVVol: 14Issue #:Start Page: 27End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013Best OA location URL: https://doi.org/10.1016/j.ymgmr.2017.10.013Citation Count: 39
-
OPENTitle: Genetic Testing for Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 1Start Page: 69End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8101316Citation Count: 39
- Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes2020OPENTitle: Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2868End Page: 2871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa287Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2868/34032411/awaa287.pdfCitation Count: 14
-
OPENTitle: Feedforward activation of PRKN/parkinJournal Name: AutophagyPublisher: Informa UK LimitedVol: 19Issue #: 2Start Page: 729End Page: 730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2022.2100615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9851250Citation Count: 9
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S155End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: http://doi.org/10.1002/mds.22781Citation Count: 62
-
OPENTitle: Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid HomeostasisJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 10Start Page: 2116End Page: 2130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1881-21.2022Best OA location URL: https://www.jneurosci.org/content/jneuro/42/10/2116.full.pdfCitation Count: 26
-
OPENTitle: Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography RadiotracersJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 6Start Page: 6462End Page: 6492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c02988Best OA location URL: https://doi.org/10.1021/acs.jmedchem.4c02988Citation Count: 4
-
OPENTitle: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 107End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004Best OA location URL: https://doaj.org/article/2232316968e3403b8d7208ad3725eaf1Citation Count: 149
-
OPENTitle: Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.021Best OA location URL: http://www.prd-journal.com/article/S1353802019300215/pdfCitation Count: 55
-
OPENTitle: Reinforcing properties of Pramipexole in normal and parkinsonian ratsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 49Issue #:Start Page: 79End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.08.005Best OA location URL: https://doaj.org/article/f2c79dbe00db45cd8b639599d5d6db7fCitation Count: 37
-
OPENTitle: Transcriptomic responses of lung mesenchymal cells during pneumoniaJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.177084Best OA location URL: https://doi.org/10.1172/jci.insight.177084Citation Count: 3
-
OPENTitle: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?Journal Name: HippocampusPublisher: WileyVol: 27Issue #: 1Start Page: 3End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22671Best OA location URL: https://archive-ouverte.unige.ch/unige:111733Citation Count: 181
- Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia2024OPENTitle: Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page: e14448End Page: e14448Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14448Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14448Citation Count: 1
-
OPENTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082617Citation Count: 37
-
OPENTitle: Alzheimer's disease‐associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brainJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 1Start Page: e14401End Page: e14401Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.14401Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14401Citation Count: 16
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S221475001730015X-fx1_lrg.jpgCitation Count: 29
-
OPENTitle: Improving Dysarthric Speech Segmentation With Emulated and Synthetic AugmentationJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 12Issue #:Start Page: 382End Page: 389Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2024.3375323Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/10464345.pdfCitation Count: 14
-
OPENTitle: Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 318End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00318Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00318/pdfCitation Count: 92
-
OPENTitle: A History of Senile Plaques: From Alzheimer to Amyloid ImagingJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 6Start Page: 387End Page: 413Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac030Best OA location URL: https://academic.oup.com/jnen/article-pdf/81/6/387/43778548/nlac030.pdfCitation Count: 33
- The impact of non-motor symptoms on physical activity in Parkinson’s disease2025OPENTitle: The impact of non-motor symptoms on physical activity in Parkinson’s diseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/17582024.2025.2607694Citation Count: 1
-
OPENTitle: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathyJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 6Start Page: 457End Page: 466Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlad026Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10209646/pdf/nlad026.pdfCitation Count: 24
-
OPENTitle: Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriersJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 83Issue #:Start Page: 115End Page: 121Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.08.011Best OA location URL: https://doaj.org/article/db7b12c187ca4b4c806a502eb4484aa6Citation Count: 155
